This partnership marks a significant milestone in the treatment of end-stage kidney disease (ESKD). By leveraging Outset Medical's Tablo, a system that simplifies and democratizes the dialysis process, U.S. Renal Care is positioned to radically enhance the quality of life for many patients. The move towards more accessible home hemodialysis underlines a shift in healthcare towards more patient-centered solutions that prioritize convenience, comfort, and control over one’s treatment schedule — essential for increasing patient engagement and overall well-being.